SGA
ABBV icon

Sector Gamma AS’s AbbVie ABBV Stock Holding History

Sector Gamma AS’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-228,500
Closed -$12.9M – 35
2014
Q2 		$12.9M Sell
228,500
-214,900
-48% -$11.3M 3.05% 13
2014
Q1 		$22.8M Buy
+443,400
New +$22.4M 5.46% 5

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sector Gamma AS's ABBV Position: Q3 2014 in Review

Sector Gamma AS sold out of AbbVie (ABBV) in Q3 2014, closing a stake of 228,500 shares — an estimated $12.9M sold.

Sector Gamma AS first reported a position in ABBV in Q1 2014 and held it in 2 quarters. The position peaked at $22.8M in Q1 2014. 1,503 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • Sector Gamma AS reported no remaining AbbVie position as of Q3 2014 after selling out during the quarter.
  • Sector Gamma AS sold 228,500 AbbVie shares in Q3 2014, an estimated $12.9M.
  • Sector Gamma AS first reported a position in AbbVie in Q1 2014 and held it in 2 quarters.
  • Sector Gamma AS's AbbVie position peaked at $22.8M in Q1 2014.
  • 1,503 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Sector Gamma AS's 13F filing for Q3 2014, filed 13 Nov 2014.